EntrolyticsMD, the world's first imaging platform for digestive diseases has been listed with the FDA. 40 Million people are affected by digestive diseases (including inflammatory bowel disease and GI cancers) costing $119.6 billion in 2018. EntrolyticsMD is already in use across over 300 investigator projects, for AI deployment and in clinical trials.
✈️ Motilent at ECCO - Bowel Wall Thickness or Bowel Wall Volume?!
EntrolyticsMD, the world's first imaging platform for digestive diseases has been listed with the FDA.
Endoscopy is now available on Entrolytics. In the cloud, on-demand, and with in-built structured reporting (right next to other tests!!)